DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, featuring promising developments across different medical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA provides a safer, extra trusted alternative for therapeutic use, especially i